Drug Discovery Unchained: What The Drug!? #2

webinar

Wed, 14 Aug 2024, 16:00 CEST (Berlin)

Dr. Alexander Neumann, BioSolveIT, Germany

Drug Discovery Unchained: What The Drug!? #2

What happens when somebody asks you to do drug discovery? No preparation, no script, no nothing. Just live performing and sharing your thoughts.

This is “What The Drug!?”: a live session tackling a drug discovery challenge using BioSolveIT tools, with the aim of reaching a conclusion in a reasonable time frame. What is the challenge? We do not know. Everything will be revealed during the stream, and we will see how things unfold.

The first session was a good starting point, but let’s see how things develop. Dive into the session, discuss together, and explore on-the-fly compound design.

Current news

category
Events
BioSolveIT at the Enamine Drug Discovery Conference 2026 in Riga
September 23, 2026 16:21 CEST
The Enamine Drug Discovery Conference in Riga (Latvia) comes to a close today. Our CEO Dr. Christian Lemmen and our SVP Application Science Dr. Marcus Gastreich spent the past four days, 20 to 23 September 2026, at the Radisson Blu Latvija Conference & Spa Hotel, and they return with much...
Read on
VAST Just Got Bigger — The September 2026 Update
September 17, 2026 09:00 CEST
More compounds. More chemistry. More opportunities to discover your next active. This August, explore Enamine’s largest compound catalog with infiniSee xREAL as BioSolveIT’s Tool of the Month. XtalPi has expanded its VAST Chemical Space, giving you access to almost six billion virtual product molecules built from over 25,000 carefully selected...
Read on
category
Events
Boston Event: Expanding Molecular Diversity with CORE
September 15, 2026 17:27 CEST
Chemical Space Exploration Meets AI in Boston BioSolveIT and Onepot.AI invite you to an evening of science, drinks, and conversation at D16, the speakeasy beneath Dillon’s in Boston. Join us on September 30, 2026, for two very concise presentations exploring how ultra-large Chemical Spaces and artificial intelligence can open new...
Read on